anmelden
NASDAQ Composite Index
25.838,94
PKT
+512,82
PKT
+2,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.10.18 | Fulton Financial overweight | Barclays Capital | |
| 03.10.18 | Columbia Sportswear Outperform | Wedbush Morgan Securities Inc. | |
| 03.10.18 | Amazon Conviction Buy | Goldman Sachs Group Inc. | |
| 02.10.18 | Alphabet A (ex Google) overweight | Morgan Stanley | |
| 02.10.18 | Amgen Outperform | Oppenheimer & Co. Inc. | |
| 02.10.18 | Comcast Buy | Pivotal Research Group | |
| 02.10.18 | Ligand Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 02.10.18 | Geron Neutral | B. Riley FBR | |
| 02.10.18 | Merit Medical Systems Buy | Needham & Company, LLC | |
| 02.10.18 | Perficient Buy | Maxim Group | |
| 02.10.18 | Netflix buy | Goldman Sachs Group Inc. | |
| 01.10.18 | Lam Research Hold | Deutsche Bank AG | |
| 01.10.18 | Applied Materials Hold | Deutsche Bank AG | |
| 01.10.18 | Vertex Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 01.10.18 | Netflix Outperform | Credit Suisse Group | |
| 01.10.18 | Microsoft Outperform | Wells Fargo & Co | |
| 01.10.18 | Microsoft Outperform | Credit Suisse Group | |
| 01.10.18 | Regeneron Pharmaceuticals Neutral | Cantor Fitzgerald | |
| 01.10.18 | Intel buy | Morningstar | |
| 01.10.18 | Intel Outperform | Wells Fargo & Co | |
| 01.10.18 | Intel Hold | Stifel, Nicolaus & Co., Inc. | |
| 01.10.18 | Intel overweight | JP Morgan Chase & Co. | |
| 01.10.18 | Intel Sector Perform | RBC Capital Markets | |
| 01.10.18 | Alphabet A (ex Google) Outperform | Macquarie Research | |
| 01.10.18 | Apple neutral | Wells Fargo & Co | |
| 01.10.18 | Apple Outperform | Macquarie Research | |
| 01.10.18 | Apple neutral | Oppenheimer & Co. Inc. | |
| 01.10.18 | Gilead Sciences Overweight | Cantor Fitzgerald | |
| 01.10.18 | Amgen buy | Jefferies & Company Inc. | |
| 01.10.18 | Amazon Outperform | Wells Fargo & Co | |
| 01.10.18 | Amazon Outperform | Macquarie Research | |
| 01.10.18 | Biomarin Pharmaceutical Overweight | Cantor Fitzgerald | |
| 01.10.18 | Biogen Overweight | Cantor Fitzgerald | |
| 01.10.18 | Amgen Neutral | Cantor Fitzgerald | |
| 01.10.18 | Methode Electronics Neutral | Robert W. Baird & Co. Incorporated | |
| 01.10.18 | Lam Research Neutral | Mizuho | |
| 01.10.18 | Intel Underweight | Barclays Capital | |
| 28.09.18 | Visa Outperform | BMO Capital Markets | |
| 28.09.18 | Ceragon Networks Outperform | Oppenheimer & Co. Inc. | |
| 28.09.18 | Alphabet A (ex Google) Conviction Buy List | Goldman Sachs Group Inc. |